Madrid, 16 January 2023.
New investments
- Revergy: Leading company in asset management and O&M for wind and solar power generation plants. Our objective is to consolidate Revergy's presence in Europe, Latin America and the United States, optimising the management and performance of wind and solar farms.
- BioClever: European Buy & Build project to create a full-service international CRO (clinical research organisation) specialising in clinical research for pharmaceutical and biotech companies. Customer focused and pursuing excellence in clinical trials.
Acquisitions of complementary portfolio companies
- Voltan strengthens its commissioning service with Aplipem: Aplipem joins the Voltan group, adding highly specialised electrical services in the assembly and commissioning phase of power generation plants and transmission infrastructures. Voltan consolidates its position as a provider of complete commissioning services.
- Defeder expands its product portfolio: Defeder closed its first incorporation in December 2022 (to be announced shortly), consolidating its position as a leading Spanish manufacturer of organic fertilisers. With this operation, Defeder broadens its product portfolio and expands its manufacturing capacity.
Portfolio performance
- Despite the turbulence of 2022, our portfolio companies have shown outstanding performance. We are proud to work closely with management teams that have achieved average annual organic growth in excess of 30%.
- Voltan has moved forward with the integration of three companies (MMYPEM, Teiga and Aplipem), consolidating its position as a provider of specialised technical services for power generation plants across Europe.
- Defeder continues to successfully execute its growth plan, adding its first additional acquisition this year with more planned for 2023. Defeder is consolidating its position as a market leader in the organic fertiliser market.
- Revergy and BioClever joined the Henko family in 2022 with ambitious plans for 2023.
Talent acquisition
- José Castellote heads portfolio management: With the hiring of José Castellote, Henko starts its portfolio team. José joins Henko from senior positions at GE Healthcare, AREVA/Alstom and Babcock. In parallel, the portfolio companies continue to attract top talent at management and board level to execute their growth plans.
Portfolio development plan
- Voltan intends to acquire several add-ons to expand its portfolio of value-added services to the energy industry and increase its presence in the transmission and distribution segment.
- Defeder will continue to grow organically while advancing its inorganic growth strategy. The company plans to acquire 2 new add-ons, primarily to expand its international reach and manufacturing capacity.
- Revergy will maintain its strong organic growth momentum based on the current order book and open new branches in strategic countries in Europe and Latin America.
- BioClever expects to grow internationally with the first acquisitions of similar CROs in other European countries. The company will start international clinical trials in 2023.
